ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹680 Cr | ₹459 Cr | ₹422 Cr | ₹293 Cr | ₹161 Cr |
What is the latest Sundry Debtors ratio of ERIS LIFESCIENCES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹680 Cr |
| Mar2025 | ₹459 Cr |
| Mar2024 | ₹422 Cr |
| Mar2023 | ₹293 Cr |
| Mar2022 | ₹161 Cr |
How is Sundry Debtors of ERIS LIFESCIENCES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹680 Cr | 48.34 | |
| Mar2025 | ₹459 Cr | 8.68 | |
| Mar2024 | ₹422 Cr | 44.17 | |
| Mar2023 | ₹293 Cr | 81.84 | |
| Mar2022 | ₹161 Cr | - | |
Compare Sundry Debtors of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹15,907.5 Cr | -3.6% | -13.6% | -25.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -3.6% |
-13.6% |
-25.2% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses